Background The relationship between the presence of antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …

We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2, …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …

We conducted voluntary Covid-19 testing programmes for symptomatic and asymptomatic
staff at a UK teaching hospital using naso-/oro-pharyngeal PCR testing and immunoassays for …

Antibody responses are an important part of immunity after Coronavirus Disease 2019 (COVID-19)
vaccination. However, antibody trajectories and the associated duration of protection …

Background Lateral flow device (LFD) viral antigen immunoassays have been developed
around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to …

Background Decisions about the continued need for control measures to contain the spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-…

Background: The COVID-19 pandemic caused> 1 million infections during January-March
2020. There is an urgent need for reliable antibody detection approaches to support diagnosis…

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin
G (IgG) antibody measurements can be used to estimate the proportion of a population …

Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …